The cost-effectiveness of Maze procedures using ablation techniques at the time of mitral valve surgery

International Journal of Technology Assessment in Health Care

Volumn 25, Issue 4, 2009, Pages 485-496

  Quenneville, Stéphane P ^a   Xie, Xuanqian ^a   Brophy, James M ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Ablation; Atrial fibrillation; Cost effectiveness analysis; Markov model; Maze; Meta analysis; Mitral valve surgery

Indexed keywords

ATRIAL FIBRILLATION; COST EFFECTIVENESS ANALYSIS; MARKOV MODEL; META-ANALYSIS; MITRAL VALVE SURGERY; MITRAL VALVES;

ABLATION; COST ACCOUNTING; COST EFFECTIVENESS; COSTS; DECISION MAKING; DECISION THEORY; MARKOV PROCESSES; SENSITIVITY ANALYSIS; TRANSPLANTATION (SURGICAL);

COST BENEFIT ANALYSIS;

ANTIARRHYTHMIC AGENT;

ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEALTH CARE COST; HEART ATRIUM FIBRILLATION; HEART VALVE SURGERY; HUMAN; LIFE EXPECTANCY; META ANALYSIS; MITRAL VALVE; MITRAL VALVE REPAIR; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; PROBABILITY; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; SURGICAL MORTALITY; SURVIVAL TIME; SYSTEMATIC REVIEW; ABLATION THERAPY; AGE; COST BENEFIT ANALYSIS; ECONOMICS; HEART SURGERY; METHODOLOGY; MORTALITY; POSTOPERATIVE COMPLICATION; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL;

ABLATION TECHNIQUES; AGE FACTORS; ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; COST-BENEFIT ANALYSIS; HUMANS; MARKOV CHAINS; MITRAL VALVE; PACEMAKER, ARTIFICIAL; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 74049112004     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462309990511     Document Type: Article

References (46)

1. Abreu Filho CA, Lisboa LA, Dallan LA, et al. Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease. Circulation. 2005;112(Suppl):I20-I25.
2. AkpinarB,GudenM, Sagbas E, et al. Combined radiofrequency modifiedmaze andmitral valve procedure through a port access approach: Early andmid-term results. Eur J Cardiothorac Surg. 2003;24:223-230.
3. Bando K, Kasegawa H, Okada Y, et al. Impact of preoperative and postoperative atrial fibrillation on outcome after mitral valvuloplasty for nonischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2005;129:1032-1040.
4. Bank of Canada. Exchange rates. http://www.bank-banquecanada ca/en/rates/converter html (accessed May 12, 2009).
5. Barreiro CJ, Patel ND, Fitton TP, et al. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly - Impact on survival and functional outcome. Circulation. 2005;112:I443-I447.
6. Baskett RJF,ButhKJ, Legare JF, et al. Is it safe to train residents to perform cardiac surgery? Ann Thorac Surg. 2002;74:1043-1048.
7. Benjamin EJ,Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death. Circulation. 1998;98:946-952.
8. Blomstrom-Lundqvist C, Johansson B, Berglin E, et al. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: The SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). Eur Heart J. 2007;28:2902-2908.
9. Borger MA,Yau TM,Rao V, Scully HE,David TE. Reoperative mitral valve replacement: Importance of preservation of the subvalvular apparatus. Ann Thorac Surg. 2002;74:1482-1487.
10. Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics. 2000;17:479-500.
11. Bronnum-Hansen H, Davidsen M, Thorvaldsen P. Long-term survival and causes of death after stroke. Stroke. 2001;32:2131-2136.
12. Deneke T, Khargi K, Grewe PH, et al. Efficacy of an additional MAZE procedure using cooled-tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized, prospective trial. Eur Heart J. 2002;23:558-566.
13. Doukas G, Samani NJ, Alexiou C, et al. Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: A randomized controlled trial. JAMA. 2005;294:2323-2329.
14. Drummond MF, Sclpher MJ, Torrance GW, O'Brien BJ, Stoddart GL, eds. Methods for the economic evaluation of health care programs. 3rd ed. Oxford: Oxford University Press; 2005.
15. Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer RM. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg. 2002;235:820-826.
16. Finlayson GS, Reimer J, Dahl M, Stargardter M, Mc-Gowan KL. The direct cost of hospitalizations in Manitoba, 2005/06. http://mchp-appserv.cpe umanitoba ca/reference/ HospCost-fullreport pdf.
17. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome - A summary of the evidence. Diabetes Care. 2005;28:1769-1778.
18. Gillinov AM, Saltman AE. Surgical approaches for atrial fibrillation. Med Clin North Am. 2008;92:203-215, xii.
19. Gouvernement du Québec. MANUEL DES MÉDECINS SPÉCIALISTES. http://www.ramq gouv qc ca/fr/profession nels/manuels/150/000-complet-acte-spec pdf (accessed July 17, 2008).
20. Handa N, Schaff HV, Morris JJ, Anderson BJ, Kopecky SL, Enriquez-Sarano M. Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg. 1999;118:628-635.
21. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year survival after first-ever stroke in the Perth Community Stroke Study. Stroke. 2003;34:1842-1846.
22. Hebeler R. Cryo Maze for the safe and effective surgical treatment of atrial fibrillation. http://www.touchcardiology com/cryo-maze-safe-effective- a256-1 html (accessed February 12, 2008).
23. Hunink MG, Glasziou P, Siegel J, Weeks J, Pliskin J, Elstein A, eds. Decision making in health and medicine: Integrating evidence and values. Cambridge: Cambridge University Press; 2001.
24. Khargi K, Hutten BA, Lemke B, Deneke T. Surgical treatment of atrial fibrillation: A systematic review. Eur J Cardiothorac Surg. 2005;27:258-264.
25. KhaykinY,Morillo CA, SkanesAC, McCracken A, Humphries K, Kerr CR. Cost comparison of catheter ablation and medical therapy in atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18:907-913. (Pubitemid 47342400)
26. Kim KC, Cho KR, Kim YJ, Sohn DW, Kim KB. Long-term results of the Cox-Maze III procedure for persistent atrial fibrillation associated with rheumatic mitral valve disease: 10-year experience. Eur J Cardiothorac Surg. 2007;31:261-266.
27. Lane DA, Lip GY. Quality of life in older people with atrial fibrillation. J Interv Card Electrophysiol. 2009;25:37-42.
28. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization: Tentative guidelines for using clinical and economic evaluations. CMAJ. 1992;146:473-481.
29. Leemis LM, Trivedi KS. A comparison of approximate interval estimators for the Bernoulli parameter. Am Stat. 1996;50:63-68.
30. Miners A, Cairns J. Probabilistic sensitivity analysis. In: Fox-Rushby J, Cairns J, eds. Understanding public health: Economic evaluation. OZGraf SA: Open University Press; 2005:171-183.
31. Miyasaka Y, Barnes ME, Gersh BJ, et al. Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: Report of a community-based study. Stroke. 2005;36:2362-2366.
32. Prasad SM, Maniar HS, Camillo CJ, et al. The Cox maze III procedure for atrial fibrillation: Long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg. 2003;126:1822-1828.
33. Public Health Agency of Canada. Major chronic diseases mortality by age group. http://dsol-smed.phac-aspc gc ca/dsol-smed/mcd-smcm/d-age-e html (accessed February 12, 2008).
34. Reston JT, Shuhaiber JH.Meta-analysis of clinical outcomes of maze-related surgical procedures for medically refractory atrial fibrillation. Eur J Cardiothorac Surg. 2005;28:724-730.
35. Sonnenberg FA, Beck JR. Markov-Models in medical decisionmaking: A practical guide. Med Decis Making. 1993;13:322-338.
36. Statistics Canada. Life tables, Canada. http://www.statcan ca/english/freepub/84-537-XIE/tables htm (accessed February 12, 2008).
37. Stewart S, Murphy N, Walker A, McGuire A, McMurray JJV. Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK. Heart. 2004;90:286-292.
38. Stulak JM, Sundt TM, Dearani JA, Daly RC, Orsulak TA, Schaff HV. Ten-year experience with the Cox-maze procedure for atrial fibrillation: How do we define success? Ann Thorac Surg. 2007;83:1319-1325.
39. Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Pharmacoeconomics. 2006;24:1021-1033.
40. Sullivan PW, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26:410-420.
41. Teng J, Mayo NE, Latimer E, et al. Costs and caregiver consequences of early supported discharge for stroke patients. Stroke. 2003;34:528-536.
42. Vickrey BG, Rector TS, Wickstrom SL, et al. Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke. 2002;33:901-906.
43. von Oppell UO, Masani N, O'Callaghan P, Wheeler R, Dimitrakakis G, Schiffelers S. Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy. Eur J Cardiothorac Surg. 2009;35:641-650.
44. WeinsteinMC, Toy EL, Sandberg EA, et al. Modeling for health care and other policy decisions: Uses, roles, and validity. Value Health. 2001;4:348-361.
45. Wierup P, Liden H, Johansson B, Nilsson M, Edvardsson N, BerglinEWO. Health care consumption due to atrial fibrillation is markedly reduced by maze III surgery. Ann Thorac Surg. 2007;83:1713-1716.
46. Wolf PA,Mitchell JB, Baker CS, KannelWB, D'Agostino RB. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 1998;158:229-234.